FDA Clearance Tracker · K251792
Stereotaxis GenesisX RMN with Navigant Workstation (NWS)
Last checked: Nov 19, 2026Latest source record: Nov 6, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Nov 6, 2025
Substantially Equivalent
Time to decision
148 days
Received Jun 11, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K251792
- Device name
- Stereotaxis GenesisX RMN with Navigant Workstation (NWS)
- Applicant
- Stereotaxis, Inc.
- Applicant location
- Saint Louis, MO
- Received
- Jun 11, 2025
- Decided
- Nov 6, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Catheter Control, Steerable (DXX)
- Device class
- Class II
- Regulation
- 21 CFR 870.1290
- Specialty
- Cardiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code DXX. The earliest in FDA's data is K904787, decided Dec 17, 1990.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K251792
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Stereotaxis, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GenesisX RMN510(k)
K262744 · Decided Aug 27, 2026 · 24 days after receipt
Device type: System, Catheter Control, Steerable (DXX) · Cardiology
- Synchrony510(k)
K253473 · Decided Apr 1, 2026 · 173 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
P240014 · Decided Jan 5, 2026 · 633 days after receipt
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.